M6PR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.579600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.415600E-03
Normal-vs-Stage2
7.489900E-02
Normal-vs-Stage3
1.946390E-02
Normal-vs-Stage4
3.306600E-01
Stage1-vs-Stage2
1.322000E-01
Stage1-vs-Stage3
1.982250E-01
Stage1-vs-Stage4
5.868200E-02
Stage2-vs-Stage3
1.298750E-01
Stage2-vs-Stage4
3.434200E-01
Stage3-vs-Stage4
5.771600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.029700E-02
Normal-vs-AfricanAmerican
8.670400E-02
Normal-vs-Asian
9.292000E-02
Caucasian-vs-AfricanAmerican
9.470600E-01
Caucasian-vs-Asian
2.714600E-01
AfricanAmerican-vs-Asian
5.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.440200E-02
Normal-vs-Female
6.760400E-02
Male-vs-Female
5.927200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.466100E-02
Normal-vs-Age(41-60Yrs)
1.988010E-01
Normal-vs-Age(61-80Yrs)
2.574200E-02
Normal-vs-Age(81-100Yrs)
5.186200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.702300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.495600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.436400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.978900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.730200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.408000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.443610E-02
Normal-vs-Daily Drinker
3.497100E-03
Normal-vs-Weekly Drinker
6.157900E-02
Normal-vs-Occasional Drinker
3.391400E-01
Normal-vs-Social Drinker
3.153000E-01
Non Drinker-vs-Daily Drinker
6.810800E-01
Non Drinker-vs-Weekly Drinker
8.110800E-01
Non Drinker-vs-Occasional Drinker
5.556900E-03
Non Drinker-vs-Social Drinker
1.227450E-01
Daily Drinker-vs-Weekly Drinker
5.730200E-01
Daily Drinker-vs-Occasional Drinker
1.961390E-03
Daily Drinker-vs-Social Drinker
1.163800E-01
Weekly Drinker-vs-Occasional Drinker
5.141700E-02
Weekly Drinker-vs-Social Drinker
3.197400E-01
Occasional Drinker-vs-Social Drinker
5.101200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.293400E-01
Normal-vs-Grade 2
1.222010E-01
Normal-vs-Grade 3
9.925700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.425600E-01
Grade 1-vs-Grade 3
5.293800E-02
Grade 1-vs-Grade 4
2.293400E-01
Grade 2-vs-Grade 3
6.296200E-02
Grade 2-vs-Grade 4
1.222010E-01
Grade 3-vs-Grade 4
9.925700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.721600E-02
Normal-vs-NonDiabetic
5.192300E-02
Diabetic-vs-NonDiabetic
7.184000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.086200E-01
Normal-vs-NoPancreatitis
3.724000E-02
Pancreatitis-vs-NoPancreatitis
7.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.341600E-02
Normal-vs-N1
6.598200E-02
N0-vs-N1
2.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.146400E-01
Normal-vs-TP53-NonMutant
1.388080E-02
TP53-Mutant-vs-TP53-NonMutant
3.340200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
